Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management, in people with hemophilia A or B
Abstract: Fitusiran is an investigational small interfering RNA therapeutic that targets antithrombin (AT) to rebalance hemostasis in people with hemophilia. Here, we present the results of a completed phase 2 open-label extension study, which evaluated the long-term safety and efficacy of fitusiran...
Збережено в:
| Автори: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2025-03-01
|
| Серія: | Blood Advances |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2473952924007110 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|